Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-7-15
pubmed:abstractText
The most effective strategy for bifurcation stenting is currently undefined. The Culotte technique was developed as a method that ensures complete bifurcation lesion coverage. However, it went out of favour due to a high rate of restenosis when utilizing bare metal stents. Drug-eluting stents reduce the rate of restenosis and need for repeat lesion revascularization compared with bare metal stents; we re-evaluated this technique with drug-eluting stent implantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1462-8848
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36-40
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16019613-Aged, pubmed-meshheading:16019613-Angioplasty, Balloon, Coronary, pubmed-meshheading:16019613-Cohort Studies, pubmed-meshheading:16019613-Coronary Restenosis, pubmed-meshheading:16019613-Coronary Stenosis, pubmed-meshheading:16019613-Coronary Vessels, pubmed-meshheading:16019613-Drug Delivery Systems, pubmed-meshheading:16019613-Female, pubmed-meshheading:16019613-Follow-Up Studies, pubmed-meshheading:16019613-Humans, pubmed-meshheading:16019613-Male, pubmed-meshheading:16019613-Middle Aged, pubmed-meshheading:16019613-Probability, pubmed-meshheading:16019613-Prospective Studies, pubmed-meshheading:16019613-Risk Assessment, pubmed-meshheading:16019613-Sirolimus, pubmed-meshheading:16019613-Stents, pubmed-meshheading:16019613-Survival Rate, pubmed-meshheading:16019613-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
pubmed:affiliation
Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't